Study: Improved Creatine Stability and pH Profile for Kre-Alkalyn®

Study Improved Creatine Stability and pH Profile for Kre-Alkalyn®

One of the most common questions we hear from brand partners is about stability. How long will this ingredient last? Will it degrade before it reaches the consumer? That’s precisely why we conducted this Kre-Alkalyn stability study—to quantify, through rigorous HPLC and accelerated testing methods, exactly how our patented pH-buffered creatine performs over time. The six-year shelf life data speaks for itself.

Improved Creatine Stability and pH Profile for Kre-Alkalyn

Jeff Golini, Ph.D.
All American Pharmaceutical, Billings, Montana

J Biosens Bioelectron 2015, 6:4

Background

Creatine (N-(aminoiminomethyl-N-methylglycine) is an important energy-producing amino acid base metabolite produced in the liver, kidneys, and pancreas. It is found in large concentrations around skeletal muscles and is absolutely essential for the health and function of every muscle cell in the body. Creatine is pivotal in delaying ATP depletion during anoxia or ischemia through the creatine-phosphocreatine system.

Creatine, in various forms, is used as a supplement to improve athletic performance. Yet, its shelf life and stomach half-life affect its bioavailability after ingestion. Previous reports suggest that creatine degradation occurs due to pH changes. At normal physiological pH, 10% of creatine has been suggested to convert to creatinine, its most common byproduct.

Various modifications to creatine intended to increase its bioavailability and stability for commercialization have been attempted.

Study Objective

The objective of this study was to assess the stability of a unique sodium bicarbonate-buffered creatine sold under the brand name Kre-Alkalyn® under various conditions.

Materials and Method

Real Time and Accelerated Stability Testing

Kre-Alkalyn® powder was assayed for purity and stability. Two samples of the same lot of Kre-Alkalyn® powder were used. A total of 1.5 grams of powder was added to 4 oz of water and stored in the lab for real-time testing. A total of 1.5 grams of Kre-Alkalyn powder was added to 4 oz of water and put into an incubator for accelerated testing. Both product groups were tested at 30-day intervals.

HPLC Analysis

Analysis performed by HPLC using Inertsil ODS-2 5 µm (250 × 4.6 mm) and 25 min. gradient elution with 0.1% phosphoric acid buffer in H20 and 0.1% phosphoric acid in acetonitrile. External reference standards obtained from Sigma-Aldrich.

FTNIR

Identification was performed by FTNIR against in-house external library standards obtained from Sigma and produced by HPLC. Quantification was performed by FTNIR using external library standards obtained from Sigma, and the samples were analyzed by HPLC (Bran and Luebbe InfraProver II FTNIR).

Stomacher

As previously described by Golini, it consists of a glass vessel containing an acid solution that mimics the stomach’s acidic environment. Creatine or Kre-Alkalyn® was first added to water, then added to the acid, and the pH was assessed over time.

pH Analysis

Creatine and Kre-alkalyn® solutions were tested for pH changes using a standard-calibrated pH meter (ATLAS Bioscience; Tucson, AZ). Three solutions were added to Kre-Alkalyn®: hydrochloric acid (0.1 ml-1M), sodium hydrogencarbonate/sodium carbonate (11.7/13.7 (ml-1M)), and ethanolamine/ethanolamine hydrochloride (18.6/ 6.3 (ml-1M)).

Results

Kre-Alkalyn® has demonstrated good 6-year stability and shelf life under accelerated testing. It maintains a high pH over time compared to normal creatine and can be augmented with additional stabilizing buffers. This stability and buffering profile may help maintain continued creatine availability.

Research Poster Presentation Image:

Dr. Jeff Golini

As the Executive Scientist of All American Pharmaceutical, Dr. Jeff Golini is the architect behind some of the most successful patented compounds in sports nutrition. From the pH-correct technology of Kre-Alkalyn® to the advanced kinetics of Karbolyn®, Dr. Golini’s work bridges the gap between rigorous clinical research and high-performance product development.